Cargando…
Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients
The pandemic of coronavirus disease 2019 (COVID-19) has infected millions of individuals around the globe. Forecasting the COVID-19 severity is essential, and various biomarkers could be used to evaluate it. The current study was therefore aimed to evaluate the serum pro-calcitonin (PCT) level as a...
Autores principales: | Waris, A., Din, M., Iqbal, N., Yar, L., Khalid, A., Nawaz, M., Baset, A., Ali, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302477/ https://www.ncbi.nlm.nih.gov/pubmed/34336223 http://dx.doi.org/10.1016/j.nmni.2021.100922 |
Ejemplares similares
-
Evaluation of hematological parameters as an indicator of disease severity in Covid‐19 patients: Pakistan's experience
por: Waris, Abdul, et al.
Publicado: (2021) -
Serum Procalcitonin Level Reflects the Severity of Cellulitis
por: Noh, Soo Hyeon, et al.
Publicado: (2016) -
Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients
por: Tang, Jinsong, et al.
Publicado: (2021) -
Serum Procalcitonin and Procalcitonin Clearance as a Prognostic Biomarker in Patients with Severe Sepsis and Septic Shock
por: Huang, Min-Yi, et al.
Publicado: (2016) -
COVID-19 outbreak: current scenario of Pakistan
por: Waris, A., et al.
Publicado: (2020)